| Catalog No. | Size | Price (USD) |
| 68208-H001-5 | 5 mg | $740.55 |
| 68208-H001-25 | 25 mg | $2,221.66 |
| 68208-H001-500 | 500 µg | $222.17 |
General Information
| Product name | Anti-CA9 (Research Grade Girentuximab Biosimilar) |
| Species reactivity | Reacts with: Human |
| Specificity | CA9 |
| Preparation | This product is a recombinant monoclonal antibody expressed from HEK293 cells. |
| Source | IgG1, Kappa |
| Purification | Protein A |
| Formulation | Histidine and Arginine buffer containing 120mM NaCl, 0.02% Tween 80, pH6.0 |
| Conjugate | Unconjugated |
| Endotoxin | ≦ 1 EU/mg |
| Form | Liquid |
| Shipping | This antibody is shipped as liquid solution at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
| Storage | Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Preservative-Free. Avoid repeated freeze-thaw cycles. |
Image / Experimental Information
| Image 1 Description | ≥95 % as determined by SDS-PAGE. |
| Image 1 Alt Text | Human CA9-Girentuximab Enzyme linked immunosorbent assay (ELISA) 46167 |
| Image 1 URL | Source image |
| Image 2 Description | ≥95 % as determined by SDS-PAGE. |
| Image 2 Alt Text | Human CA9-Girentuximab Enzyme linked immunosorbent assay (ELISA) 46168 |
| Image 2 URL | Source image |
title: Characterization of residual cancer by comparison of a pair of organoids established from a patient with esophageal squamous cell carcinoma before and after neoadjuvant chemotherapy.
authors: Takafumi Fuchino; Shusaku Kurogi; ...; Naoki Hijiya
journal: Human cell
date: 2024-01-06
pmid: 38184488
doi: 10.1007/s13577-023-01020-3
cited_by_count: 2
techniques: Formalin-fixed Paraffin-Embedded; Immunohistochemistry; In Vitro
bioz_score: 92
